Education
School ¡X Major ¡X Degree | Duration |
---|---|
°ª¶¯Âå¾Ç¤j¾Ç ¡X ÃľǬã¨s©Ò(²¦) ¡X ³Õ¤h Doctorate, Graduate Institute of Pharmaceutical Science, Kaohsiung Medical University |
1997/09 ¡X 2002/06 |
°ª¶¯Âå¾Ç¤j¾Ç ¡X ÃľǨt(²¦) ¡X ¾Ç¤h Bachelor, School of Pharmacy, Kaohsiung Medical University |
1993/09 ¡X 1997/06 |
Intramural Experience
Office/Department/Institute | Position | Duration |
---|---|---|
»ùÛ«~¾Ç¨t Department of Fragrance and Cosmetic Science | Professor | 2015/02/01 ¡X |
»ùÛ«~¾Ç¨t Department of Fragrance and Cosmetic Science | Associate Professor | 2010/08/01 ¡X 2015/01/31 |
»ùÛ«~¾Ç¨t Department of Fragrance and Cosmetic Science | Assistant Professor | 2007/08/01 ¡X 2010/07/31 |
Extramural Experience
DEPNO | Position- Office/Department/Institute | Duration |
---|---|---|
¤¤¥x¬ì§Þ¤j¾Ç©ñ®g§Þ³N¨t | §U²z±Ð±Â | 0930801 ¡X 0960731 |
Discipline
NO | Discipline | Expertise |
---|---|---|
1 | ¥Íª«Âå¹AÃþ Biology, Medicine and Agriculture | ÃľǤΤ¤ÂåÃÄ Pharmacy and Chinese Medicine and Pharmacy |
2 | ¦ÛµM¬ì¾ÇÃþ Natural Sciences | ¤Æ¾Ç Chemistry |
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
»Ýn¤ÀªR§Þ³Nªº³æ¦ì
Anyone who needs analytical technology
Area(s) of Expertise & Research
¥Íª«¤ÀªR¤èªk¶}µo¡BÃĪ«¡B¹«~¤ÎùÛ«~¤¤¦³®Ä»P¦³®`¦¨¤À¤ÀªR¡B¼Ë«~«e³B²z¡B²G¬Û¤Î®ð¬Û¼hªR¡B½èÃФÀªR
Bioanalytical method development; Analysis of active or harmful compounds in drugs, food, and cosmetics; Sample pretreatment; Liquid and gas chromatography; Mass spectrometry
Publication
NO | Publication |
---|---|
1 | Molecularly imprinted dispersive micro solid-phase extraction and tandem derivatization for the determination of histamine in fermented wines. Molecularly imprinted dispersive micro solid-phase extraction and tandem derivatization for the determination of histamine in fermented wines. |
2 | A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells. A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells. |
3 | Fluorescence detection of apolipoprotein E gene polymorphisms based on oligonucleotide ligation and magnetic separation. Fluorescence detection of apolipoprotein E gene polymorphisms based on oligonucleotide ligation and magnetic separation. |
4 | ¨Ï¥Î´§µo©Êl¥Í¸Õ¾¯§Ö³t¥Ò°ò¤Æ¤H¦å¼ß¤¤ªºõé¨F©Z¡A¥H´£°ª¨ä¦b MALDI-TOF ½èÃФÀªR¤¤ªºÆF±Ó«× Rapid methylation of valsartan in human plasma using evaporative derivatization reagent to improve its sensitivity in MALDI-TOF mass spectrometry |
5 | A macrolide from Streptomyces sp. modulates apoptosis and autophagy through Mcl-1 downregulation in human breast cancer cells. A macrolide from Streptomyces sp. modulates apoptosis and autophagy through Mcl-1 downregulation in human breast cancer cells. |
6 | Antitumor Effects of a Sesquiterpene Derivative from Marine Sponge in Human Breast Cancer Cells. Antitumor Effects of a Sesquiterpene Derivative from Marine Sponge in Human Breast Cancer Cells. |
7 | ¹«~¤¤¤»ºØ¥Íª«Ói¤§¦P®Él¥Í¤Æ¤Î²G©T¬ÛÅÜ·LµÑ¨úªk·f°t¯¶ºÞ²G¬Û¼hªR-µµ¥~¥ú°»´ú Simultaneous derivatization and liquid-solid phase transition microextraction of six biogenic amines in foods followed by narrowbore liquid chromatography-ultraviolet detection |
8 | ¼ö·l¶Ë±wªÌ¤§ºC©ÊµÇŦ¯e¯fªº·ÀI¡G¤@¶µ¥xÆWÁa³e©Ê¥@¥N¬ã¨s Risk of chronic kidney disease in patients with heat injury: A nationwide longitudinal cohort study in Taiwan |
9 | °t¦X¶WÁn´õ¬y»²§U¤À´²²G²G·LµÑ¨ú»P°ª®Ä²G¬Û¼hªR-¤G·¥ºÞ°}¦C°»´ú¾¹ÀË´ú¤ÆùÛ«~©M¤HÅ騤½è¼h¤¤ªºµµ¥~½u¹LÂo¾¯ Ultrasound-Vortex-Assisted Dispersive Liquid-Liquid Microextraction Combined with High Performance Liquid Chromatography-Diode Array Detection for Determining UV Filters in Cosmetics and the Human Stratum Corneum |
10 | ¤ßŦ¿}苷£\lDiginoside³q¹L½Õ¸`¤HÃþ¤fµÄÅ쪬Àù²ÓM¤¤Mcl-1ªº§Ü¸~½F¬¡©Ê Antitumor Activity of the Cardiac Glycoside £\lDiginoside by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells |
11 | ·Lªi»²§Ul¥Í¤ÏÀ³µ²¦X¾®»E´£¨úªk¨Ã°t¦X¤ò²ÓºÞ²G¬Û¼hªRªk´ú©w¥Íª«°ò½è¼Ë«~¤¤ªº½\¯Ö¥Ì肽 Microwave-assisted derivatization combined with coacervative extraction for determining glutathione in biomatrix samples, followed by capillary liquid chromatography |
12 | §Q¥Î¨âºØ·LµÑ¨úªk°t¦X¤ò²ÓºÞ²G¬Û¼hªR»ö-µµ¥~¥ú°»´ú¾¹´ú©w¹ïßm°òf¥Ò»Äà Determination of parabens using two microextraction methods coupled with capillary liquid chromatography-UV detection |
13 | ¶Wµªi»²§Ul¥Í¤ÏÀ³¦X¨Ö¤ò²ÓºÞ¹qªa´ú¶q¥Íª«¼Ë«~¤¤¤Ñ¥V®ò»Ä©M¨¦®ò»Ä¤§¹ï´x²§ºcª«»Pªü´þ®üÀq¯g¶i®i¤§Ãö«Y Enantioselective determination of aspartate and glutamate in biological samples by ultrasonic-assisted derivatization coupled with capillary electrophoresis and linked to Alzheimer¡¦s disease progression |
14 | ³n¬À·ä¤§SterolÃþ¤Æ¦Xª«»¤¾ÉMCF-7¨Å¸¢Àù²ÓM¤§²ÓMä¤`»P¦Û¾½§@¥Î A Sterol from Soft Coral Induces Apoptosis and Autophagy in MCF-7 Breast Cancer Cells |
15 | ¥H½èÃлö¤ÀªR¹ïßm°òf¥Ò»Äà¤Î¨ä¥NÁª« Derivatization-Enhanced Detection Strategy in Mass Spectrometry: Analyze 4-Hydroxybenzoate and Survey their Metabolites after Human Keratinocytes Exposed to UV Radiation |
16 | ¥H®ð¬Û¼hªR½èÃлö·f°t¦êÁp¦¡l¥Íªk¤ÎÆQªR»²§U²G²G·LµÑ¨úªk¤ÀªR§¿²G¤¤ªº¥Íª«²¸¾J Tandem derivatization combined with salting-out assisted liquid¡Vliquid microextraction for determination of biothiols in urine by gas chromatography¡Vmass spectrometry |
17 | ¿Ã¥úl¥Í¦X¨Ö¤ô·»©Ê·»´C¤À´²²G²G·LµÑ¨úªk¤ÀªR¤HÅé¦å¼ß¤¤¤§butyrobetaine, l-carnitine©Macetyl-l-carnitine Fluorescent derivatization combined with aqueous solvent-based dispersive liquid-liquid microextraction for determination of butyrobetaine, l-carnitine and acetyl-l-carnitine in human plasma |
18 | §Q¥Î·Lªi»²§Ul¥Í°t¦X¤À´²²G²G·LµÑ¨úªk¤ÀªR¤£¦P¼Ë«~°ò½è¤¤¤§¶Ç©ú»Ä Determination of tranexamic acid in various matrices using microwave-assisted derivatization followed by dispersive liquid-liquid microextraction |
19 | §Q¥Î·LM±Y¸Ñ¤ò²ÓºÞ¹qªa½u¤W¿@ÁY§Þ³N¤ÀªR¨¾Å⣫~¤¤ªºµµ¥~¥ú§l¦¬¾¯ Determining ultraviolet absorbents in sunscreen products bycombining direct injection with micelle collapse on-linepreconcentration capillary electrophoresis |
20 | ¥HGC/MS¤ÀªRºëªo¤¤¤§phenylpropenes¦¨¤À Dual dispersive liquid¡Vliquid microextraction for determination of phenylpropenes in oils by gas chromatography¡Vmass spectrometry |
21 | Application of Central Composite Design for the Determination of Exfoliating Agents in Cosmetics by Capillary Electrophoresis with Electroosmotic Flow Modulation Application of Central Composite Design for the Determination of Exfoliating Agents in Cosmetics by Capillary Electrophoresis with Electroosmotic Flow Modulation |
22 | ¤Æ¾Çl¥Í°t¦X¤ò²ÓºÞ²G¬Û¼hªR©Î°ò½è»²§U¹p®g²æªþ´åÂ÷-¸¦æ®É¶¡½èÃЪk·L¶q¤ÀªR¤ÆùÛ«~¤¤²¸¨¯»Ä¨Ã¾ã¦X¤HÃþ¨¤½è²ÓM³J¥Õ½èªí²{ Chemical derivatization combined with capillary LC or MALDI-TOF MS for trace determination of lipoic acid in cosmetics and integrated protein expression profiling in human keratinocytes |
23 | ¤À´²²G²G·LµÑ¨úªk¦X¨Ö·Lªi»²§Ul¥Í¤ÏÀ³´ú¶q§¿²G¤¤²¸¨¯»Ä¤Î¨ä¥NÁª« Dispersive liquid-liquid microextraction combined with microwave-assisted derivatization for determining lipoic acid and its metabolites in human urine |
24 | §Q¥ÎÀô½kºë×¹¢¤ò²ÓºÞ¹qªaªkµ²¦X¹êÅç³]pªk¥H°»´ú¤ÆùÛ«~¤¤¦hºØßm°ò»Ä Determination of hydroxy acids in cosmetics by chemometric experimental design and cyclodextrin-modified capillary electrophoresis |
25 | §Q¥Î¤ò²ÓºÞ²G¬Û¼hªRªk°t¦Xµµ¥~¥ú°»´ú¾¹·L¤p¤Æ©w¶q¤ô¼Ë«~¤Î¤ÆùÛ«~¤¤¤QºØ¾Ff¤G¥Ò»ÄàÃþ:¦³®Ä´î¤Ö¦³¾÷¼o²G¤§µ¦²¤ Micro-scale quantitation of ten phthalate esters in water samples and cosmetics using capillary liquid chromatography coupled to UV detection: effective strategies to reduce the production of organic waste |
26 | §Q¥Î©`¦Ì²G¬Û¼hªR°t¦X¦êÁp¦¡½èÃлöªì¨B¿z¿ïacrylamide©Mglycidamide¤§¥Dn¦å¼ß³J¥Õ½è×¹¢ Modification of major plasma proteins by acrylamide and glycidamide: Preliminary screening by nano liquid chromatography with tandem mass spectrometry |
27 | §Q¥Î½èÃаt¦X¸¦æ®É¶¡¤ÀªR¾¹©w¶q¤HÅé¦å¼ß¤¤irbesartan¤Î¥Dn³J¥Õ½è Quantitation of irbesartan and major proteins in human plasma by mass spectrometry with time-of-flight analyzer |
28 | §Q¥Î©`¦Ì¤Æ²G¬Û¼hªR¦êÁp½èÃлöŲ©wMES-13²ÓM¤¤ANGIOTENSIN II (1-8)¥NÁª«:ªì¨B¥¥x IDENTIFICATION OF THE METABOLITES OF ANGIOTENSIN II (1-8) IN MES-13 CELLS BY A SIMPLE NANOLC-MS-MS SYSTEM: A PRELIMINARY PLATFORM |
29 | §Q¥Î°ò½è»²§U¹p®g²æªþ¸¦æ®É¶¡½èÃЪk°t¦Xquinolone°ò½è²K¥[¾¯©w¶q¤ÀªR¤HÅé¦å¼ß¤¤quinapril Quantitation of quinapril in human plasma by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with quinolone matrix additives |
30 | §Q¥Î°ò½è»²§U¹p®g²æªþ¸¦æ®É¶¡½èÃЪk°t¦X·L¤p¤Æl¥Í¤ÏÀ³©w¶q¤ÀªR¤HÅé©PÃä¦å²G¤§glutathione Quantitation of the glutathione in human peripheral blood by matrix-assisted laser desorption ionization time-of-flight mass spectrometry coupled with micro-scale derivatization |
31 | §Q¥Î¤GºØ¸`¬Ù·»´C¤è¦¡¤ÀªRQuinapril:À³¥Î¤ò²ÓºÞ°ªÀ£²G¬Û¼hªRªk°t¦Xµµ¥~¥ú°»´ú¾¹¤ÎLDI-TOF-MS Analysis of Quinapril by Two Solvent-Saving Methods: Application of Capillary Column High-Performance Liquid Chromatography with Ultraviolet Absorbance Detection and LDI-TOF-MS |
32 | ¥H·L¦Ìµ¥¯Å¼Ò¦¡°»´ú¦åºÞ¦¬ÁY¯ÀÂà´«»Ã¯À§í¨î¾¯§ëÃÄ«e«á¤HÅ駿²G¤¤¥Dn³J¥Õ½èªºÅÜ¤Æ A Micro-Scale Model to Monitor the Major Proteins in Human Urine Before and After Medication with Angiotensin-Converting Enzyme Inhibitor: A Preliminary Study |
33 | §Q¥Î¤Gºû¹qªa°t¦XZipTip¤Î¦Û¦æ²Õ¸Ë¤§©`¦Ì¬yÅé¨t²Î°µ³J¥Õ½èŲ©w Protein identification from two-dimensional gel electrophoresis by connecting ZipTip with a home-assembled nanoflow system |
34 | §Q¥Î²G¬Û¼hªR-¦êÁp¦¡½èÃлö¦b·L¤Éµ¥¯Å¦å¼ß¤¤¤ÀªR¦åºÞ¦¬ÁY¯À±µ¨üÅé«ú§Ü¾¯¤Î³J¥Õ½è¼Ð°O Analysis of angiotensin II receptor antagonist and protein markers at microliter level plasma by LC¡VMS/MS |
35 | ¶}µo§C¤À¤l¶q¤Æ¦Xª«°ò½è¨ÃÀ³¥Î©ó§Q¥Î°ò½è»²§U¹p®g²æªþÂ÷¤l¤Æ-¸¦æ®É¶¡½èÃлö¤ÀªRPÀùÂb·}ÆP A New Matrix for Analyzing Low Molecular Mass Compounds and Its Application for Determination of Carcinogenic Areca Alkaloids by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry |
36 | §Q¥Î½èÃлö¦b·L¤Éµ¥¯Å¤ÀªR¤HÅé¦å¼ß¤¤Glyclazide Trace Analysis of Glyclazide in Human Plasma at Microscale Level by Mass Spectrometry |
37 | §Q¥Î©`¦Ìµ¥¯Å²G¬Û¼hªR¤Î¦êÁp¦¡½èÃлö¤ÀªRÁ{§ÉÆP©Ê¤Æ¦Xª« Determination of Clinically Very Basic Compounds by Nanoscale Liquid Chromatography with Tandem Mass Spectrometry |
38 | ¤HÅé¦å¼ß¤¤Methylxanthines¤§§Ö³t¤ÀªR Rapid simultaneous determination of three methylxanthines in human plasma by capillary electrophoresis |
39 | l¥Í¤Æ°ªÀ£²G¬Û¼hªR¹ïtobramycin©ó¦å¼ß¤¤¤§·L¶q¤ÀªR¬ã¨s trace analysis of tobramycin in human plasma by derivatization and high-performance liquid chromatography with ultraviolet detection |
40 | l¥Í¤Æ²G¬Û¼hªR¹ïamikacin¤§·L¶q¤ÀªR Trace analysis of amikacin by derivatization and high performance liquid chromatography |
41 | °ª®Ä¯à²G¬Û¼hªRªk¹ï¤HÅé¦å¼ß¤¤amikacin¤§·L¶q¤ÀªR Trace analysis of amikacin in human plasma by high performance liquid chromatography |
42 | l¥Í¤Æ²G¬Û¼hªR¹ï¥«°âamikacin»s¾¯¤§·L¶q¤ÀªR Trace analysis of amikacin in commercial preparation by derivatization and HPLC |
Project
NO |
YEAR ¡X Source ¡X No ¡X Type
Project Name
|
Duration |
---|---|---|
1 |
113 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC113-2113-M-037-010 ¡X 1 Ó¤H«¬
¥i¤Á´«¤À¤l²GÅé·LµÑ¨úªkµ²¦X§Ö³tl¥Í¤ÏÀ³¶i¦æ·L¶q¤ÀªR(2/3)( )
|
2024/08/01 ~ 2025/07/31 |
2 |
113 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NK113P15 ¡X 1 Ó¤H«¬
«e¦C¸¢Àù²ÓM¥H¸¬ÄªÖJ¤T萜Ãþ¤Æ¦Xª«¦³µL·f°t²§²¸Ùæ»Äà¦@¦PªvÀøªº§ÜÀù¬¡©Ê±´°Q¤Î¤ÀªR(Discovery and analysis of antitumor activity of the cucurbitane triterpenoid in prostate cancer cells co-treatment with and without isothiocyanates)
|
2024/01/01 ~ 2024/12/31 |
3 |
112 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSTC112-2113-M-037-018 ¡X 1 Ó¤H«¬
¥i¤Á´«¤À¤l²GÅé·LµÑ¨úªkµ²¦X§Ö³tl¥Í¤ÏÀ³¶i¦æ·L¶q¤ÀªR(1/3)( )
|
2023/08/01 ~ 2024/07/31 |
4 |
112 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X ¡X 1 Ó¤H«¬
±´°Q©T¾JÃþ¤ÑµMª«ªº§ÜGÀù²ÓM¬¡©Ê¤Î¨ä¥Íª«¼Ð»xª«¤ÀªR(Discovery of antitumor activity of the sterol in gastric cancer cells and biomarker analysis)
|
2023/01/01 ~ 2023/12/31 |
5 |
111 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST111-2113-M-037-018 ¡X 1 Ó¤H«¬
µo®i´¼¯à»E¦Xª«¤Îºñ¦âl¥Íªk©ó·L¶q¤ÀªR¤§À³¥Î(3/3)( )
|
2022/08/01 ~ 2023/07/31 |
6 |
110 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST110-2113-M-037-020 ¡X 1 Ó¤H«¬
µo®i´¼¯à»E¦Xª«¤Îºñ¦âl¥Íªk©ó·L¶q¤ÀªR¤§À³¥Î(2/3)( )
|
2021/08/01 ~ 2022/07/31 |
7 |
110 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X ¡X 1 Ó¤H«¬
±´°Q¤@Ó®üºø¤§¿¥b萜Ãþ¦üª«ªº§Ü¨xÀù²ÓM¬¡©Ê¤Î¨ä·L¶q¤ÀªRªk¶}µo( )
|
2021/01/01 ~ 2021/12/31 |
8 |
109 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST109-2113-M-037-010 ¡X 1 Ó¤H«¬
µo®i´¼¯à»E¦Xª«¤Îºñ¦âl¥Íªk©ó·L¶q¤ÀªR¤§À³¥Î(1/3)( )
|
2020/08/01 ~ 2021/07/31 |
9 |
109 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU109-P004 ¡X 1 Ó¤H«¬
±´°Q¤@ÓÃìÅðµßÄݤ§¤jÀô¤ºàÃþ¦üª«ªº§Ü¨ÅÀù²ÓM¬¡©Ê¤Î¨ä·L©w¶q¤ÀªR( )
|
2020/01/01 ~ 2020/12/31 |
10 |
108 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST108-2113-M-037-003 ¡X 1 Ó¤H«¬
µo®i±M¤@©Ê¤§©T¬Û·LµÑ¨úº[¸ûÀô«Ol¥Í§Þ³N(2/2)( )
|
2019/08/01 ~ 2020/07/31 |
11 |
108 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU108-P008 ¡X 1 Ó¤H«¬
±j¤ß°tÁÞÅédivaricoside §@¬°¤fµÄÀùªvÀø¼Ð¹v¤§±´¨s¤Î¨ä»P¦hÓi¥Íª«¼Ð»xª«ªº·L¶q¤ÀªR( )
|
2019/01/01 ~ 2019/12/31 |
12 |
107 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSUKMU107-P011 ¡X 1 Ó¤H«¬
"G ³J¥Õ½è½¢¦X¨üÅé30¡A¤@Ó½¤°Ê±¡¯À¨üÅé§@¬°GÀùªvÀø¼Ð¹v¤§±´¨s¤Î¨ä ·L¤p¤Æ©w¶q¤ÀªR¬ã¨s"( )
|
2018/01/01 ~ 2018/12/31 |
13 |
107 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST107-2113-M-037-011 ¡X 1 Ó¤H«¬
µo®i±M¤@©Ê¤§©T¬Û·LµÑ¨úº[¸ûÀô«Ol¥Í§Þ³N(1/2)( )
|
2018/08/01 ~ 2019/07/31 |
14 |
106 ¡X NK °ªÂå-¤¤¤s¦X§@pµe ¡X NSYSKMU106P005 ¡X 1 Ó¤H«¬
BI-D1870 ½Õ±±¯ØŦÀù²ÓMä¤`¤Î¨ä·L¤p¤Æ©w¶q¤ÀªR¬ã¨s( )
|
2017/01/01 ~ 2017/12/31 |
15 |
106 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST106-2113-M-037-006 ¡X 1 Ó¤H«¬
·L¶q¤ÀªR¥Î§Ö³tl¥Íº[·LµÑ¨úªk¶}µo(2/2)( )
|
2017/08/01 ~ 2018/07/31 |
16 |
106 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST106-2811-M-037-003 ¡X 9 ³Õ¤h«á¬ã¨sû
³Õ¤h«á¬ã¨sû--®}¤å®i( )
|
2017/08/01 ~ 2018/07/31 |
17 |
105 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST105-2113-M-037-015 ¡X 1 Ó¤H«¬
·L¶q¤ÀªR¥Î§Ö³tl¥Íº[·LµÑ¨úªk¶}µo(1/2)( )
|
2016/08/01 ~ 2017/07/31 |
18 |
105 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP105PR05 ¡X
¤p¤À¤l·¥©Ê¤Æ¦Xª«l¥Íª«Å²©wº[¤ÀªR¤èªk¶}µo( )
|
2016/12/01 ~ 2017/10/31 |
19 |
105 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST105-2811-M-037-007 ¡X 9 ³Õ¤h«á¬ã¨sû
³Õ¤h«á¬ã¨sû--®}¤å®i( )
|
2016/10/12 ~ 2017/07/31 |
20 |
105 ¡X Z ¤j±M¾Ç¥Í¬ã¨spµe¤Î³Õ¤h«á ¡X MOST106-2813-C-037-011-M ¡X 8 ¤j±M¾Ç¥Í¬ã¨spµe
106¦~«×¤j±M¾Ç¥Í¬ã¨spµe-Ĭ¯§Åï(»ùÛ3)( )
|
2017/07/01 ~ 2018/02/28 |
21 |
104 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST104-2113-M-037-009 ¡X 1 Ó¤H«¬
µo®i¸ûºñ¦âl¥Í¤ÏÀ³¤Î·L¤p¤ÆµÑ¨úªkÀ³¥Î©óÓi°ò»Ä²¸¾J¤ÀªR( )
|
2015/08/01 ~ 2016/07/31 |
22 |
104 ¡X TP ³»¦ypµe(°ªÂå) ¡X KMU-TP104PR07 ¡X
µo®iÀô«O¥B§Ö³t¤§¤ÀªR¤èªkÀ³¥Î©ó¦×ÆP¤Î¨ä¬ÛÃö¤Æ¦Xª«ªºÀË´ú( )
|
2015/12/01 ~ 2016/09/30 |
23 |
103 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X MOST103-2113-M-037-002 ¡X 1 Ó¤H«¬
§Q¥Î·LµÑ¨ú§Þ³N¤Îl¥Í¤ÏÀ³·L¤p¤Æ¤ÀªR¥\¯à©ÊÓi°ò»Ä¤Î¨ä¬¡©ÊÃþ¦üª«( )
|
2014/08/01 ~ 2015/07/31 |
24 |
102 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC102-2113-M-037-012 ¡X 1 Ó¤H«¬
·L¤p¤Æ¤ÀªR¾É¦V¤§«e³B²z¤Îl¥Í¤èªk¦b¥Íª«ÀË«~¤§À³¥Î( )
|
2013/08/01 ~ 2014/07/31 |
25 |
101 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC101-2113-M-037-002 ¡X 1 Ó¤H«¬
µo®i·L¤p¤Æ¤ÀªR¤èªk¦X¨Öl¥Í¤ÏÀ³°»´ú¦Ñ¤Æ¬ÛÃö¯e¯f¤§¥NÁ½ո`¾¯( )
|
2012/08/01 ~ 2013/07/31 |
26 |
100 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC100-2113-M-037-003 ¡X 1 Ó¤H«¬
§Q¥Î¸`¬Ù·»´C«e³B²z¤è¦¡°t¦X·L¤p¤Æ¤ÀªRªk´ú©w¤ß¦åºÞ¥NÁ¯e¯f±wªÌÅ餺ÃĪ«¤Î§Ü®ñ¤Æª«½è( )
|
2011/08/01 ~ 2012/07/31 |
27 |
099 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC99-2113-M-037-004 ¡X 1 Ó¤H«¬
¿}§¿¯f¦X¨Ö°ª¦åÀ£±wªÌÅ餺¦åºÞ¦¬ÁY¯ÀII±µ¨üÅé«ú§Ü¾¯¤Î¨ä¬ÛÃö¥Í²z¬¡©Êª«½è¤ÀªR( )
|
2010/08/01 ~ 2011/07/31 |
28 |
098 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC97-2113-M-037-008-MY2 ¡X 1 Ó¤H«¬
§Q¥Î¤ò²ÓºÞ²G¬Û¼hªRªk¤ÀªR¦åºÞºòÁY¯ÀÂà´«»Ã¯À§í¨î¾¯¤Î¨ä¬ÛÃö¥NÁª«½è(2/2)( )
|
2009/08/01 ~ 2010/07/31 |
29 |
097 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC97-2113-M-037-008-MY2 ¡X 1 Ó¤H«¬
§Q¥Î¤ò²ÓºÞ²G¬Û¼hªRªk¤ÀªR¦åºÞºòÁY¯ÀÂà´«»Ã¯À§í¨î¾¯¤Î¨ä¬ÛÃö¥NÁª«½è(1/2)( )
|
2008/08/01 ~ 2010/07/31 |
30 |
097 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X KMU-Q098002 ¡X
¦b·L¤Éµ¥¯Å§Q¥Î¤ò²ÓºÞ²G¬Û¼hªR¤ÀªR( )
|
2009/01/01 ~ 2009/12/31 |
31 |
096 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC95-2113-M-037-025 ¡X 1 Ó¤H«¬
§Q¥Î¤ò²ÓºÞ¹qªa©M¤ò²ÓºÞ²G¬Û¼hªRªk¤ÀªRÁ{§É¥Íª«ÀËÅ餤¿}§¿¯f¥ÎÃĤ§¬ã¨s( )
|
2006/08/01 ~ 2007/12/31 |
32 |
096 ¡X N °ê¬ì·|(ì¬ì§Þ³¡) ¡X NSC96-2113-M-037-016 ¡X 1 Ó¤H«¬
§Q¥Î·L¤p¤Æºñ¦â¤ÀªR¤Æ¾Ç§Þ³NºÊ´ú°¦åÀ£ÃÄ»PµÇ¯À-¦åºÞ¦¬ÁY¯À¨t²Î¤¤ªº¦åºÞ¦¬ÁY¯ÀÐ`肽( )
|
2007/08/01 ~ 2008/07/31 |
33 |
096 ¡X Q ·s¸u±Ð®vpµe(®Õ¤º) ¡X ¡X
§Q¥Î·L¶q¯Å²G¬Û¼hªR¤ÀªRSulfonylureaÃþÃĪ«( )
|
2007/11/01 ~ 2008/07/31 |
34 |
096 ¡X Y °ªÂå-¹ü°ò¦X§@pµe ¡X 97-CCH-KMU-009 ¡X 1 Ó¤H«¬
·L¶q¤ÀªR¥Íª«ÀËÅ餤¤§AT1±µ¨üÅé«ú§Ü¾¯( )
|
2008/01/01 ~ 2008/12/31 |
Patent
NO | Patent Name | Country | Certified Date | Patent No |
---|---|---|---|---|
1 | ¾Ff¤G¥Ò»ÄàÃþ¤§¤ÀªR¤èªk | ¤¤µØ¥Á°ê | 2014/07/01 | I443323 |
2 | ÁCf¤G¥Ò»ÄàÃþªºµÑ¨ú¤èªk | ¤¤µØ¥Á°ê | 2018/11/11 | I640758 |
3 | °w¹ïßn»Ä°ò¹Îªº§Ö³tl¥Í¤èªk¤Î¦×ÆPÃþ¤Æ¦Xª«ªº¤ÀªR¤èªk | ¤¤µØ¥Á°ê | 2017/06/01 | I585067 |
4 | °w¹ï§C¤À¤l¶q¤Î°ª·¥©Ê¤§¥|¯ÅÓi¤Æ¦Xª«¤§¤ô©Ê·»¾¯¤À´²²G²G·LµÑ¨úªk | ¤¤µØ¥Á°ê | 2017/05/21 | I583659 |
5 | ¨ã£^-ßn»Ä°ò¤§¥|¯Å»Ï¤Æ¦Xª«ªºÀË´ú¤èªk¡B¦×ÆP¯Ê¥F¯gªº¶EÂ_¤èªk¤Î¥Î¥HÀË´ú¨ã£^-ßn»Ä°ò¤§¥|¯Å»Ï¤Æ¦Xª«ªº®M²Õ | ¤¤µØ¥Á°ê | 2018/07/21 | I630387 |
6 | ¨ã£^-ßn»Ä°ò¤§¥|¯Å»Ï¤Æ¦Xª«ªºÀË´ú¤èªk | ¬ü°ê | 2020/07/07 | 10,703,969 |
7 | ½\¯Ö¥Ì?ªºÀË´ú¤èªk¤Î¨ä®M²Õ | ¤¤µØ¥Á°ê | 2018/07/01 | I628435 |
8 | ½\¯Ö¥Ì?¤§©w¶qÀË´úªk¤Î¸Õ¾¯®M²Õ | ¬ü°ê | 2020/04/21 | 10,627,406 |
9 | ¨ã£^-ßn»Ä°ò¤§¥|¯Å»Ï¤Æ¦Xª«ªºÀË´ú®M²Õ | ¬ü°ê | 2021/05/25 | 11,016,096 |
10 | ¥Íª«ÓiªºÀË´ú¤èªk¤ÎÀË´ú®M²Õ | ¤¤µØ¥Á°ê | 2022/01/01 | I751875 |